Epilepsy and Seizure Disorders
Condition(s) | Type of Drug | Phase | Add-On | Placebo | Duration | Open Label Extension |
---|---|---|---|---|---|---|
Partial Seizures | Novel potassium blocker | II | Yes | 20% | 20 weeks | To market |
Response Form
If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or use the form below. One of our skilled Clinical Research Coordinators will contact you as soon as possible. Thank you for your interest in our research!
- Stephen S. Flitman, MD, Medical Director